FDA Clearance of the DeltaScan® Brain State Monitor
UTRECHT, The Netherlands, March 15, 2023 – Prolira BV, a high-tech company committed to enabling...
2 minutes read
Prolira Appoints Dominic Spadafore as Chief Executive Officer
Seasoned medtech executive with over two decades of industry experience and a proven track record...
1 minute read
Innovative approach to delirium by Santeon nurses
Santeon (a group of 7 topclinical hospitals in the Netherlands) introduces a new approach to...
1 minute read
Growth capital investment for Prolira for roll-out of brain state monitoring to hospitals
Investors Borski fund, ROM Utrecht Region, Holland Capital, Health Innovations and Oost NL together...
4 minutes read
DeltaStudy successfully completed
In this multicenter study, 434 patients measured with DeltaScan. A large scale validation study for...
1 minute read
Label extension for DeltaScan with acute encephalopathy
We are proud to announce that the intended use for DeltaScan® has been expanded. It now also...
0 minute read
EU MDR certification for Prolira DeltaScan!
Regulatory Milestone: Prolira has EU MDR certification! We are proud to announce that Prolira is...
0 minute read
The Epidemic within the Covid19 Pandemic: Delirium
Article in New York Times (may 2020): Scores of phycisians from around the world report a rise in...
1 minute read
Delirium care in St Antonius
St Antonius hospital is one of the first users of DeltaScan, the objective EEG based device to...
0 minute read